Lamivudine is an antiviral medication that belongs to the nucleoside reverse transcriptase inhibitors (NRTIs) class. It works by inhibiting the replication of viruses, specifically the HIV virus and hepatitis B virus, in the body. This helps control these infections, reducing viral load, improving immune function, and preventing the progression of diseases.
Approved by the U.S. Food and Drug Administration (FDA) in 1995 for HIV treatment, lamivudine exporter has since become a critical component of antiretroviral therapy (ART) for managing HIV/AIDS. Additionally, it was later approved for treating chronic hepatitis B, where it suppresses the virus to prevent liver damage and complications such as cirrhosis and liver cancer.